Clinical Trials
3 trialsNCT04865419 2025-06-15
Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
AstraZeneca
Phase 1 Terminated
NCT05205161 2025-01-07
A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma
AstraZeneca
Phase 1 Terminated
NCT04214093 2023-08-02
A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors
AstraZeneca
Phase 1 Terminated